Lymphomas are divided into two large groups of diseases often referred to as non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (sometimes called Hodgkin lymphoma). Each year, there are approximately 74,000 cases of lymphoma diagnosed in the United States. What makes lymphoma sometimes challenging to manage is the fact that it is not one, but 65 different diseases, each with its own unique clinical behavior and frequently requiring its own specific treatment.
Multiple Myeloma Research
NYUCI researchers are investigating the fundamental biology of multiple myeloma and developing and assessing new therapies for this disease. Our goal is to improve the outcome of patients with multiple myeloma using targeted therapies that will have greater effectiveness and fewer side effects than conventional approaches.